Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Not likley to accumulate following multpile dosing; OECD Guideline 417
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
The pharmacokinetics of the test item showed that it was rapidly absorbed and eliminated and did not accumulate following repeated administration. The bioavailability of the test item decreased from 30.2% to 5.58%, indicating a saturation in absorption as the dose increased from 50 mg/kg bw to 1000 mg/kg bw.
In a second study, following oral gavage administration of 20 and 500 mg/kg, the bioavailability (F) were 65.90 ± 43.37% and 34.42 ± 27.57% respectively. In the 7 days repeated oral administration of 20 mg/kg of test material, the bioavailability and exposure in rat body were both slightly decreased, with no accumulation. Absorbed test material was distributed in the whole body of the rat. The concentration of test material in each organ had not reduced significantly. After oral administration of test material at 20 mg/kg, the cumulative % average excretion in feces and urine were 15.3951 ± 15.9400% and 0.7239 ± 0.3189%, and 16.1190% in total. The test material excreted via feces was unabsorbed unchanged test material. Absorbed test material, which has been entered the systemic circulation, would be partly excreted via urine and bile as unchanged test material. Test material could be metabolically transformed in rats, dogs and human liver microsomal incubation system, especially quick in rat and dog liver microsomes. The main enzyme for metabolizing the test material was CYP19, secondly with CYP4, CYP2C9, CYP2E1, CYP1A2 and CYP2D6 did not metabolize test material.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
